Halozyme Therapeutics, Inc. (HALO) Posts Mixed Q3 Results

November 8, 2013 8:03 AM

Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported Q3 EPS of ($0.17) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found